@OLovikka@CamillusLellis Shorts wont lose on this news unfortunately. Good start though. I truly hope they do soon..still need the company to continue to grow revenue
@spaventa7@stocklllovers6 Market makers do what they want Jane street made over 39 billion (revenue )fixing the market last year . Citadel made over 12.2 billion( revenue) you can't tell me they aren't doing this to ibrx
@KhaledAli661661@yachmod@ImmunityBio Must be shorting it by putting that fishing article up . Morning star is probably funded by Jane street and other companies shorting ibrx
@BillMur81205942@gainzalgo 2016 study published in The BMJ tracked hematology-oncology medical reviewers who left the FDA between 2001 and 2010. It found that 58% (15 out of 26) of those who left the agency went on to work or consult for the biopharmaceutical industry. That's how they get paid off
@BlauBerlin84974 I've heard this 4 over a month...the shorts are in trouble. Continued great news and approvals around the world . Revenue was great and yet stock drops and drops... It seems the only people in trouble are the investors. The shorts as of now seem to be winning . I hope I'm wrong.
@Oshin76 I'm tempted everyday Monday to Thursday to sell an opening by halfway through the day and play the game because Friday comes around and options expire and this happens. But then again, I don't want to miss out when it skyrockets and I know it will
@KYPRIANOUS Welcome to old news but welcome to say the least . Buy the stock while it's low here under 7.48 and enjoy the ride up. Eventually it's got to take off with the constant good news .